Cell Growth & Differentiation, Vol 6, Issue 3 315-323, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues

DH Gutmann, RT Geist, DE Wright and WD Snider
Center for the Study of Nervous System Injury, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

The neurofibromatosis 1 (NF1) gene encodes a large M(r) approximately 250,000 phosphoprotein, the expression of which in adult tissues is limited to neurons, Schwann cells, oligodendrocytes, adrenal medulla, and leukocytes. The presence of two alternatively spliced exons (23a and 48a) in the NF1 gene allow for the generation of four possible neurofibromin isoforms. Type 1 neurofibromin contains neither 23a or 48a exon sequences, while type 2 neurofibromin contains only the 23a exon insertion. Previous studies have demonstrated that types 1 and 2 neurofibromin might have different functional properties relative to microtubule association and GTPase-activating protein activity towards p21-ras. To determine the normal pattern of expression of these NF1 isoforms, the adult and developmental expression of types 1 and 2 NF1 was examined. Herein, we demonstrate that NF1 mRNA is expressed at varying levels in adult tissues and is developmentally regulated during embryogenesis. Neurons in the central nervous system express predominantly type 1 NF1. Using mouse neocortical cultures enriched for neurons or glial cells, type 1 NF1 predominance was demonstrated in neurons, while type 2 NF1 predominated in glial cells. In contrast to central nervous system neurons, neurons expressing the type 2 NF1 isoform were identified in the developing dorsal root ganglia and spinal cord by in situ hybridization using a type 2-specific oligonucleotide probe. The elucidation of the differential expression pattern of these two NF1 isoforms during development and in adult life provides the foundations for future studies aimed at determining the functions of these neurofibromin isoforms.

This article has been cited by other articles:

				P. Balestri, R. Vivarelli, S. Grosso, L. Santori, M. A. Farnetani, P. Galluzzi, G. P. Vatti, F. Calabrese, and G. Morgese Malformations of cortical development in neurofibromatosis type 1 Neurology, December 23, 2003; 61(12): 1799 - 1801. [Abstract] [Full Text] [PDF]

				D. H. Gutmann, J. Donahoe, A. Perry, N. Lemke, K. Gorse, K. Kittiniyom, S. A. Rempel, J. A. Gutierrez, and I. F. Newsham Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas Hum. Mol. Genet., June 12, 2000; 9(10): 1495 - 1500. [Abstract] [Full Text] [PDF]

				D. H. Gutmann Learning Disabilities in Neurofibromatosis 1: Sizing Up the Brain Arch Neurol, November 1, 1999; 56(11): 1322 - 1323. [Full Text] [PDF]

				V. Aaltonen, P. J. Bostrom, K.-O. Soderstrom, O. Hirvonen, J. Tuukkanen, M. Nurmi, M. Laato, and J. Peltonen Urinary Bladder Transitional Cell Carcinogenesis Is Associated with Down-Regulation of NF1 Tumor Suppressor Gene in Vivo and in Vitro Am. J. Pathol., March 1, 1999; 154(3): 755 - 765. [Abstract] [Full Text] [PDF]

				T. Rosenbaum, K. M. Patrie, and N. Ratner Neurofibromatosis Type 1: Genetic and Cellular Mechanisms of Peripheral Nerve Tumor Formation Neuroscientist, November 1, 1997; 3(6): 412 - 420. [Abstract] [PDF]